Unlocking Insights: How the CannaMama Study at Wayne State is Transforming Our Understanding of Cannabis Use and Maternal Health

While working as a public health nurse in Detroit, Biyyiah A. Strickland, a Ph.D. student at Wayne State University, frequently encountered a pressing question from expectant mothers: “Is it safe to use cannabis during pregnancy?” These women weren’t defying advice; they were seeking honest answers amidst mixed messages.

Strickland’s research, the CannaMama Study, dives into cannabis use among pregnant and postpartum women in Detroit. Preliminary findings indicate that about 26% of pregnant women in the study reported cannabis use, which is significantly higher than the national average. This highlights the complexity of cannabis consumption in urban areas, where cultural attitudes often vary.

“They’re getting conflicting information,” Strickland explained. On one hand, friends and online communities suggest cannabis can safely ease morning sickness and anxiety. On the other, healthcare providers often advise pregnant women to avoid it entirely due to potential risks to fetal development. Strickland noticed a significant gap between women’s real experiences and public health messaging.

Pregnancy can amplify feelings of stress and uncertainty. Strickland aims to listen to these women’s stories without judgment. Understanding why women turn to cannabis is key, along with recognizing the influence of their social circles. The study looks to guide education and support based on empathy and evidence.

The CannaMama Study is part of the Cannabinoids in Neurodevelopment (CANDID) research division, led by Dr. Hilary Marusak. The goal is to understand how cannabis affects mental health and brain development. Recent data show that the lack of accurate information can leave women feeling isolated. According to a study by the American College of Obstetricians and Gynecologists, about 70% of women feel confused about cannabis use during pregnancy.

Strickland’s research is crucial for addressing health equity and understanding community needs. It reflects her belief that community context affects health decisions significantly. “The women here are resilient but face barriers like access to care and stigma,” she said. This research serves as a bridge to better care.

As part of the follow-up study, CannaMama 2.0, Strickland’s team plans to explore how the body’s endocannabinoid levels relate to pregnancy outcomes. They aim to recruit women in the Detroit area who are pregnant or have recently given birth to share their cannabis experiences.

Strickland hopes this research will improve healthcare providers’ education, prenatal care, and public health messaging in Michigan. It’s about fostering conversations around cannabis use in safe, supportive environments. “When someone mentions using cannabis, that’s not just data; it’s a story of coping and stress,” she said. The aim is to create health systems that listen and react with compassion.

Amidst evolving conversations about cannabis, the CannaMama Study stands out as a vital step in bridging gaps in knowledge and care. It highlights the importance of community voices in shaping public health discussions. By understanding individual narratives, healthcare can become more responsive and equitable.



Source link